Disordered Electron Transfer: New Forms of Defective Steroidogenesis and Mitochondriopathy

Area of Science:

• Endocrinology
• Genetics
• Biochemistry

Background:

• Steroidogenesis disorders, like congenital adrenal hyperplasia (CAH), often stem from mutations in cytochrome P450 enzymes.
• These enzymes require electron transfer, typically via P450 oxidoreductase (POR) for microsomal enzymes or ferredoxin reductase (FDXR) and ferredoxin (FDX) for mitochondrial enzymes.
• POR deficiency is a known cause of CAH, affecting hydroxylase activities and potentially causing Antley-Bixler syndrome.

Purpose of the Study:

• To highlight the role of FDXR in steroidogenesis and iron-sulfur cluster synthesis.
• To report recent findings linking FDXR mutations to neurological disorders and adrenal insufficiency.
• To emphasize the need for endocrine assessment in patients with FDXR mutations.

Main Methods:

• Review of recent genetic and clinical findings in patients with FDXR mutations.
• Analysis of the biochemical roles of FDXR in electron transfer and iron-sulfur cluster synthesis.
• Clinical case observations linking FDXR mutations to specific symptoms.

Main Results:

• FDXR mutations are associated with visual impairment, optic atrophy, hearing loss, and developmental delay, mimicking mitochondrial disorders.
• Patients with FDXR mutations may experience severe, life-threatening infections and adrenal insufficiency.
• Adrenal insufficiency, previously predicted, has now been clinically documented in individuals with FDXR mutations.

Conclusions:

• FDXR plays a critical role beyond steroidogenesis, including iron-sulfur cluster synthesis essential for various enzymes.
• Neurologists, neonatologists, and geneticists should consider endocrine evaluation for patients with FDXR mutations.
• Early endocrine consultation can aid in the diagnosis and management of adrenal insufficiency in these complex cases.